On 10 November 2023, PERISCOPE contributed to the IMI/IHI impact series on vaccines titled “How IMI projects facilitate innovations in vaccine development and effectiveness assessment”. As part of the event, former coordinator, Prof. Dimitri Diavatopoulos (RadboudUMC), introduced the PERISCOPE project, its contribution to pertussis research and...
The PERISCOPE (PERtussIS COrrelates of Protection Europe) Consortium met in Ghent, Belgium, from May 16 to 18, 2022 for its final meeting before project end in August 2022.
RESEARCH SESSION:Pertussis: the road towards effective controlDate:Tue, Oct 27, 2020Session Time:17:00 - 18:30 CETRoom:Hall 3organized by the PERISCOPE consortiumChairs:Dimitri Diavatopoulos (Radboud University Medical Center) and Ulrich Heininger (University of Basel Children’s Hospital)
17:00: Short introduction on PERISCOPEDimitri...
Starting the year with full force – In January 2020, Dimitri Diavatopoulos, Assistant Professor from Radboud University Medical Center in the Netherlands paid a visit to the PERISCOPE GaPs trial site in The Gambia. The immunologist and WP2- leader used his time in Africa to support the work at the site and meet the local staff. In the course of...
Use your chance to give input to future objectives for EU-funded research and innovation which will contribute to the “strategic plan” and priorities of Horizon Europe’s first four years (2021-2024). You can participate by providing your input through the online survey (it takes approximately 20 minutes to respond).
The public online consultation...
From April 3rd to 5th the PERISCOPE project participants came together in Salamanca (Spain) for this year’s annual meeting. The three day event, kindly hosted by the University of Salamanca (USAL), was filled with dynamic discussions about the progress of the project, several scientific workshops and inspiring presentations by the young...
This trial is part of the infant studies conducted under the PERISCOPE consortium and its only arm in Africa.
We are investigating the immune responses of infants who receive either acellular or whole cell pertussis vaccine at 2, 3 and 4 months of life, in line with the usual vaccination schedule and the other recommended infant vaccines.
Congratulations are in order: Hans de Graaf from the University of Southampton was honoured with the IDWeek 2018 International Investigators Award. He received the prize in recognition of excellence in his abstract submitted to IDWeek 2018: “A Bordetella pertussis Human Challenge Model Induces Immunizing Colonization in the Absence of Symptoms”....
The conference “Clinical Trials in Infectious Disease - From Diagnosis to Clinic (CTIDC2018)” premiered in London, UK from July 02-03 2018.
CTICD2018 was targeted at scientists and clinicians in the field of Infection, pharmaceutical, biomedical and medical device industries, clinical research organisations and research networks. The conference...
Since the launch of IMI2 in 2014, the intensified vaccine focus of the program has resulted in the support of 14 vaccine-focused project consortia – with PERISCOPE being one of them. Philippe Denoel (GSK) and Patricia Londono-Hayes (SP) as EFPIA representatives within our project have co-authored a comment that was recently published in NATURE...
The PERISCOPE project has released its 4th newsletter including the latest updates on the project’s progress. You can download the fourth issue of the newsletter now. We hope that you will enjoy reading the latest news of PERISCOPE!
… and we are proud to be part of its success! See how IMI is working to overcome some of biggest medical challenges: http://bit.ly/IMITenYears
Further activites of IMI this year are the following big events:
27 June: 'IMI: celebrating 10 years of medical innovations' (jointly organised with the EC and EFPIA) – please note...
This year’s annual meeting was loaded with dynamic scientific discussions, inspiring young researcher presentations and dedicated work group meetings. The project participants came together in Lyon, France from March 7-9, 2018 for a 2.5 day event hosted by Sanofi Pasteur.
The European Commission (EC) launched an open public consultation on possible activities for stronger EU cooperation against vaccine preventable diseases. The initiative shall be implemented in 2018 following feedback from interested individuals on 1) tackling vaccine hesitancy, 2) sustainable vaccine policies in the EU and 3) EU coordination,...
The PERISCOPE project has released its 3rd newsletter including the latest updates on the project’s progress. You can download the third issue of the newsletter now. We hope that you will enjoy reading the latest news of PERISCOPE!
The second PERISCOPE clinical study – the BERT study – carried out on behalf of the Dutch National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM) has started. In the first week of October, 2017, the first patient took part in the clinical study which is conducted at the Spaarne Gasthuis in...
The EU infrastructure project TRANSVAC offers high-quality technical services free of charge to promote the development of prophylactic and therapeutic vaccines for both human and animal use.
TRANSVAC aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal...
From September 13 – 15, 2017 a three day workshop on the development and standardisation of Bp-specific T-cell and B-cell ELISpot assays was held in the Netherlands.
Organizer and host of the workshop was the PERISCOPE team at the Dutch National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM)...
The PERISCOPE project has released its 2nd biannual newsletter including the latest updates on the project’s progress.
You can download the second issue of the newsletter now. We hope that you will enjoy reading the project’s latest news!
The first PERISCOPE clinical study is about to start - on April 27th, 2017, the future team that will be involved in the implementation of the study came together for a site initiation visit at NIHR Wellcome Trust Clinical Research Facility in Southampton, UK.
The study team discussed the trial protocol, the monitoring plan and requirements and...
From March 8-10 the PERISCOPE Consortium came together for its annual meeting in Prague (Czech Republic), the hometown of the project partner Institute of Microbiology of the ASCR, v. v. i. (IMIC), to discuss the project’s progress and future collaboration.
On December 16, 2016, the Steering Committee of the PERISCOPE project came together in Leiden, NL for the third time to discuss the project’s progress and to align activities throughout the different work packages. All present work package leaders and co-leads from the industry partners summarized their activities to date and discussed overarching...
From March 2nd to 4th, 2016, the PERISCOPE consortium came together in Dublin, Ireland for officially starting project activities that will now be continued for a total duration of 60 months. The Kick-off Meeting was hosted by PERISCOPE partner Kingston Mills from Trinity College Dublin and took place in the nearby Davenport Hotel located in the...